Hematopoietic stem cells (HSC), the self-renewing cells of the adult blood differentiation hierarchy, are generated during embryonic stages. The first HSCs are produced in the aorta-gonad-mesonephros (AGM) region of the embryo through endothelial to a hematopoietic transition. BMP4 and Hedgehog affect their production and expansion, but it is unknown whether they act to affect the same HSCs. In this study using the BRE GFP reporter mouse strain that identifies BMP/Smad-activated cells, we find that the AGM harbors two types of adult-repopulating HSCs upon explant culture: One type is BMP-activated and the other is a non-BMP-activated HSC type that is indirectly controlled by Hedgehog signaling through the VEGF pathway. Transcriptomic analyses demonstrate that the two HSC types express distinct but overlapping genetic programs. These results revealing the bifurcation in HSC types at early embryonic stages in the AGM explant model suggest that their development is dependent upon the signaling molecules in the microenvironment.
INTRODUCTION
The first definitive long-term repopulating hematopoietic stem cells (HSCs) originate in the aorta-gonad-mesonephros (AGM) region at mouse embryonic day 10.5 (E10.5) (Medvinsky and Dzierzak, 1996) and emerge from hemogenic endothelial cells lining the aorta and other arteries through endothelial to hematopoietic transition (Jaffredo et al., 1998; de Bruijn et al., 2002; North et al., 2002; Zovein et al., 2008; Chen et al., 2009; Boisset et al., 2010) . HSCs are found in hematopoietic clusters closely associated with the vasculature and are in an exclusively ventral position in the aorta (Taoudi and Medvinsky, 2007) , highlighting the importance of positional information within the growing embryo. Indeed, in avian embryos ventralizing factors such as vascular endothelial growth factor (VEGF), bone morphogenetic protein 4 (BMP4), basic fibroblast growth factor (bFGF), and transforming growth factor b (TGF-b) are hematopoietic cell inductive, whereas dorsalizing factors such as epidermal growth factor and TGF-a are inhibitors (Pardanaud and Dieterlen-Lievre, 1999) . After their generation, HSCs colonize other hematopoietic sites including the fetal liver (FL), where they are greatly expanded (Medvinsky and Dzierzak, 1996; Ema and Nakauchi, 2000; Kumaravelu et al., 2002; Gekas et al., 2005) . HSCs migrate again just before birth and colonize the bone marrow (BM) where they reside throughout adult life in endothelial and osteoblastic niches (Mendelson and Frenette, 2014) . Thus, the establishment of the vertebrate hematopoietic system is a temporally and spatially controlled ontogenic process that depends on inducing factors and/or growth factors in the different developmental niches.
A key factor in hematopoietic development is BMP4, which is required during different embryonic stages, beginning at the time of gastrulation and mesoderm formation (Winnier et al., 1995) and playing a central role in the hematopoietic specification of mesodermal cells (Zhao, 2003; Pearson et al., 2008) . Mice lacking Bmp4 die in utero before the onset of blood formation. Loss of Bmp4 endows the embryo with ''dorsalized'' characteristics and decreases the ventral lineages including hematopoietic cells, vessels, and the pronephric kidney. In contrast, an increase in the ventral lineages is observed when Bmp4 is overexpressed (Gupta et al., 2006) . Similar effects of BMP4 are observed in Xenopus, and in zebrafish ventrally localized Bmp4 induces the blood stem cell program in the dorsal aorta (Wilkinson et al., 2009; Huber et al., 1998) . In the mouse and human AGM region, ventrally localized BMP4 expression in the endothelial and mesenchymal cells underlying the emerging hematopoietic cluster cells (Marshall et al., 2000; Durand et al., 2007 ) is thought to influence HSC generation. Indeed, BMP4 increases HSC activity in mouse AGM explants and reaggregates (Durand et al., 2007; Kim et al., 2015) . Moreover, all AGM HSCs in vivo are BMP activated (Crisan et al., 2015) .
Another developmental regulator, Hedgehog (Hh), acts as a morphogen in many developing tissues. Visceral endoderm is instructive to the development of endothelial and hematopoietic cells through Hh signaling early in mouse gastrulation (Belaoussoff et al., 1998; Dyer et al., 2001) . Hh protein can replace endodermal tissue (gut) to induce HSCs in AGM explant cultures before the normal onset of HSC generation (Peeters et al., 2009) . Zebrafish Hh pathway mutants display significant defects in HSC formation, and Hh factors act upstream of VEGF to regulate definitive hematopoiesis in the embryo (Gering and Patient, 2005) .
Although BMP4 and Hh, when studied individually, have been shown to influence HSC growth, it is unknown whether these signaling pathways intersect in the same HSCs. In this study, we make use of BMP Responsive Element (BRE) GFP transgenic mice to study the BMP signaling pathway and the effects of Hh simultaneously on AGM HSC development. We show in explant cultures that the AGM contains two types of HSCs, BMP-activated and non-BMP-activated HSCs, with distinct but overlapping genetic programs. The non-BMP-activated HSC type is lost when the Hh signaling pathway is inhibited, but can be partially rescued by VEGF. We reveal here the signaling pathway regulation involved in the bifurcation of HSC types during development.
RESULTS
BMP and Hedgehog Factors Affect HSC Activity in Serum-Free AGM Explants Although BMP4 and Hedgehog factors individually influence HSC growth, it is unknown whether these signaling pathways intersect to control HSCs. To address this question, we used AGM explant culture (AGM ex ) as a tractable system by which the specific effect of BMP4 or Shh individually, or in combination, on HSCs could be examined. E11 AGM explants were cultured for 3 days in serum-free medium to eliminate the contribution of growth factors known to be present in serum. When tested by transplantation into irradiated adult recipients, no HSCs were found in the AGM ex in the absence of serum (none repopulated of six transplanted recipients) compared with 40% of recipients repopulated (two of five) with HSCs from AGM ex in medium containing serum ( Figure 1A) . When BMP4 or Shh were added to serum-free AGM ex , 33% of transplanted mice (two repopulated of six transplanted) were high-level, long-term reconstituted ( Figure 1A) (Crisan et al., 2015) . Our data showed that all AGM HSCs in vivo (AGM in ) are BMP activated whereas at later ontogenic stages in vivo (in the E14 FL and adult BM), two distinct HSC types exist: BMP activated and non-BMP activated (Crisan et al., 2015) . Surprisingly, when E11 AGM explants from BRE GFP transgenic embryos were cultured for 3 days in serumcontaining medium followed by transplantation of GFP + and GFP À sorted cells into irradiated adult mice, HSCs were found in both fractions ( Figure 1B ). Six out of seven recipients receiving GFP + and three out of five recipients receiving GFP À AGM ex cells were high-level, multilineage engrafted at 4 months post transplantation. These HSCs were self-renewing, as shown by secondary transplantations ( Figure S1 ). Thus, in contrast to AGM in , the explant culture of the AGM reveals the existence of two HSC types: BMP activated and non-BMP activated. Figure 1B ).
qRT-PCR revealed that transcripts for Ihh, Gli1, and Vegf were increased 4.7-fold (p = 0.03), 2.5-fold (p = 0.02), and 3.5-fold (p = 0.002), respectively in AGM ex compared with AGM in , further supporting the active nature of these signaling pathways in the explant culture ( Figure 1C) . Interestingly, RNA sequencing data from sorted GFP + and GFP À cells in the hematopoietic progenitor/stem cell (legend continued on next page) Figure 1D ). This upregulation is not found when cyclopamine is added. In general, Gli1 FPKMs are low in the HPSC. The OC fraction shows high levels of Gli1 expression before and after explant that is only slightly decreased in the presence of cyclopamine. Together, these data demonstrate that Hh signaling affects non-BMP-activated AGM ex HSCs most likely through ECs, with VEGF acting downstream of the Hh pathway activation to control these HSCs.
The AGM ex Microenvironment Allows the
Development of the Two HPSC Types
The cellular composition of BRE GFP AGM ex compared with AGM in was examined by flow cytometric analysis.
In AGM in , phenotypic HPSCs are present in both fractions and in absolute number are slightly more abundant (1.7-fold) in the GFP À fraction (p = 0.03) (Figures 2A and 2B ).
HPSCs are found also in both GFP + and GFP À AGM ex fractions ( Figure 2C ). In absolute number, the AGM (Figure 4A) . GO terms for immune response, cell cycle, metabolism, and transcription were found to be significantly upregulated in the GFP À HPSC fraction ( Figure 4B ).
Furthermore, gene sets with TCF3, SOX9, NRIP1, Zfx, and CCND1 upregulated genes were significantly upregulated in the BMP-activated HPSCs, while gene sets of the downregulated genes were significantly upregulated in (E) High-magnification image of an immunostained E11 BRE GFP aortic cluster (CD31, magenta; cKit, red; GFP, green the non-BMP-activated HPSCs ( Figure 4C ). Most of these genes are abnormal in different types of leukemia-TCF3 and NRIP1 in lymphoblastic leukemia (Hartsink-Segers et al., 2015; Lapierre et al., 2015; Somasundaram et al., 2015) , CCND1 in chronic myeloid leukemia (Gerber et al., 2013) , Sox9 in promyelocytic leukemia (Djouad et al., 2014) , and Zfx, a component transcription factor of LIF and BMP signaling pathways, in HSCs (Galan-Caridad et al., 2007; Chen et al., 2008) . Gene list enrichment analysis further shows that gene sets with NIPBL, SALL4, and Suz12 upregulated genes were significantly upregulated in the non-BMP-activated HPSCs while their downregulated target genes were significantly upregulated in BMP-activated HPSCs, suggesting a possible role in the regulation of non-BMP-activated HPSCs ( Figure 4D ). NIPBL is a partner of the ETV6 transcription factor in acute megakaryoblastic leukemia (Kuleszewicz et al., 2013; de Braekeleer et al., 2013) , and Sall4 is constitutively active in acute myeloid leukemia (Ma et al., 2006; Zhang et al., 2015) .
Transcripts of key HSC transcription factors such as Runx1, Gata2, Lmo2, Fli1, Etv6, and Gfi1b were found in both HPSC fractions, before and after explant, although at varying levels ( Figure 5A ). The transcription factors Sox17, required for endothelial to hematopoietic cell transition (Clarke et al., 2013) , and Erg, required for definitive hematopoiesis (Loughran et al., 2008) , were highly specific for BMP-activated HSCs, as no/low transcripts were found in the non-BMP-activated HSCs in both AGM in and AGM ex . In contrast, hematopoietic cell marker genes ckit, Itga2b, and Ptprc, although expressed in both fractions, were higher in the non-BMP-activated AGM ex HPSCs CD93 (AA4.1), and CD34 was more highly expressed in the BMP-activated HPSCs ( Figure 5B ). Genes of typical endothelial markers Pecam 1 (CD31), Cdh5 (VE-cadherin),
Eng (endoglin, CD105), Tek (Tie-2), and wWF (von Willebrand factor) were more highly expressed in the BMP-activated HPSCs compared with non-BMP-activated HPSCs suggesting their hemogenic endothelial origin ( Figure 5C ). These observations are consistent with data demonstrating that all HSCs in vivo express VE-cadherin at the time of their generation (Chen et al., 2009 ) and that endoglin initiates hematopoietic commitment from the mesoderm by activating the BMP pathway (Borges et al., 2012) . Dendrogram analysis shows that HPSCs are closer to GFP + ECs than to GFP À ECs in both AGM in and AGM ex ( Figure 5D ), suggesting that the hemogenic endothelium is also BMP activated. Thus, based on transcriptome data, BMP-activated HPSCs express a more hemogenic endothelial molecular program, whereas the non-BMP-activated HPSC program is highly hematopoietic. Since the non-BMP-activated HSCs develop in AGM ex ,
we next looked for changes in the biological processes (GO terms) of the surrounding cells that may form part of the microenvironment. The OC ( Figure 4E ) and EC (Figure 4F ) fractions significantly upregulate genes related to ECM and metabolism in AGM ex compared with AGM in .
The immune response GO term is significantly represented in OCs ( Figure 4E ) while signaling pathways, development, and migration process are upregulated in the EC ( Figure 4F ). Thus, a complex microenvironment in AGM ex appears to support the two HSC types early in development.
DISCUSSION
We initiated this study to examine the interface of two developmental signaling pathways in AGM HSCs. Rather than converging on the same HSCs, BMP and Hh pathways were found to regulate two distinct HSC types: BMP-activated and non-BMP-activated Hh/VEGF-responsive HSCs. The appearance of non-BMP-activated HSCs in this culture system was unexpected, since we found the percentage of BMP-activated cells was increased in AGM explants. It is likely that the explant culture conditions affect both the + cKit À ) compared with the AGM in EC and OC, respectively. In (C) and (D), the Fisher exact test was performed for each gene set by comparing the number of GFP + or GFP À genes and their overlap to each other. The calculated p values from Fisher exact tests were corrected for multiple testing using the FDR method. In all other panels, FDR correction for multiple testing was performed on chi-squared test outcomes from the Enrichr web tool. generation and growth of AGM HSCs. The absence of the tissues surrounding the AGM dorsally and ventrally, such as the neural tube and gut, respectively, may contribute to changes in the HSC composition by altering the positional information. Normally the dorsal microenvironment is restrictive to HSC growth in vivo (Peeters et al., 2009; Pardanaud and Dieterlen-Lievre, 1999 ) and its absence in AGM explants may explain the appearance of the non-BMP-activated HSC type. Our recent demonstration of the two HSC types in the FL (Crisan et al., 2015) suggests that the explant culture of AGM induces a bifurcation of HSCs into an FL-like state. In the AGM explant, the non-BMP-activated HSCs are exclusively sensitive to cyclopamine treatment and provide no hematopoietic engraftment upon transplantation, whereas the BMP-activated HSCs are unaffected. Importantly, HSC activity can be partially restored in cyclopamine conditions when VEGF is exogenously added. It would be interesting to know whether the non-BMP-activated HSCs in the FL are also controlled by Hh/VEGF signaling, and an appropriate culture system should be developed to test this. However, it is known that at E11 both Hh and Gli1 (Cridland et al., 2009; Hirose et al., 2009 ) are expressed in the FL, and thus may influence the second type of HSC in this tissue.
The role of Hh signaling in HSC development is unclear, and published data regarding this have been in conflict (reviewed in Lim and Matsui, 2010; Mar et al., 2011) . Fifty percent of germline Ihh À/À mouse embryos die at E13.5 from hematological disorders, the stage when HSCs are highly expanding in the FL microenvironment (reviewed in Kaimakis et al., 2013) . In these mice, erythroid lineage differentiation is profoundly affected (Cridland et al., 2009 ), but surprisingly phenotypic (LSK) HSC numbers remain unchanged. In contrast, Gli1 À/À BM LSK HSCs transplanted into adult recipients show a higher engraftment efficiency compared with wild-type HSCs, and myeloid development is adversely affected (Merchant et al., 2010) . Both these results could be explained by our results showing that not all HSCs are regulated by Hh, and we suggest that BMP-activated HSCs fill in for the Hh-regulated HSCs in the deficient mice. However, downstream of the HSC, Hh is necessary in progenitors and for erythroid lineage differentiation. The AGM explant culture is known to increase HSC activity. Whether the increase in AGM explant HSCs is due to the expansion and shift in BMP-activation status of existing HSCs, or the new generation of HSCs (non-BMP-activated), or both, remains unclear. Secondary transplantations of GFP + and GFP À BM cells from the primary recipients who received GFP + AGM explant cells clearly demonstrate that BMP-activated AGM cells can give rise to non-BMP-activated HSCs in the recipient BM microenvironment. However, it is also possible that the non-BMPactivated HSCs are generated from GFP À ECs, which we found by RNA sequencing to highly express Gli1 after explant. In aortic clusters, non-BMP-activated hematopoietic cells are found together with BMP-activated hematopoietic cells, supporting the notion that heterogeneity of HSCs can occur at an early developmental stage. However, our data suggest that the AGM in does not offer the right microenvironment for the development of the second HSC type. Only the AGM explant culture model facilitates study of the two HSC types and their regulation. Others have shown the existence of pre-HSCs in reaggregate AGM cultures or in the early FL (Taoudi et al., 2008; Kieusseian et al., 2012) , and neonatal engrafting HSCs have been described in the E9 yolk sac (Yoder and Hiatt, 1997) . These may represent the precursors to the non-BMP-activated (Hh/VEGF-responsive) HSCs. It will be interesting in future studies to examine these cells and the early hematopoietic tissues in the context of BMP, as well as Hh signaling through fate-mapping approaches. Our RNA sequence datasets show that transcription factors known to be involved in hematopoietic cell development are expressed in both the BMP-activated and non-BMP-activated AGM HPSC fractions, suggesting that these genes are not exclusively regulated by BMP signaling. In contrast and importantly, Sox17 a known target of the BMP signaling pathway (Teo et al., 2012) is strictly expressed in the BMP-activated HPSC and EC AGM fractions ( Figure 5E ). Since Sox17 is required for endothelial to hematopoietic cell transition and since all AGM HSCs in vivo are BMP activated (Crisan et al., 2015) , our data suggest that BMP-activated HSCs arise from BMP-activated ECs. This is further reinforced by the dendrogram generated from our RNA sequencing datasets, showing the close relationship of HPSCs to BMP-activated ECs ( Figure 5D ).
In conclusion, we show here that the BMP and Hh/ VEGF signaling pathways control two HSC types in the AGM explant culture. BMP-activated HPSCs differ in their intrinsic molecular program from the non-BMP-activated Hh responsive HPSCs, and the molecular program of cells within the AGM niches changes upon explant, thus implicating the microenvironment in the control of the distinct HSC types. This knowledge is of high interest to human health, since Hh antagonists are used today as anti-cancer and anti-leukemic drugs (Von Hoff et al., 2009; Amakye et al., 2013) . There is a correspondence of drug resistance in acute myeloid leukemia (AML) patients (Zahreddine et al., 2014) with high Gli1 expression. Our data also show that the gene targets of decitabine, a drug used today to treat patients with myelodysplastic syndrome and AML (Kantarjian et al., 2003; Kantarjian et al., 2006) are significantly upregulated in the BMP-activated HSCs and significantly downregulated in the non-BMP-activated HSCs ( Figure 4C ), suggesting that the two HSC types do not respond similarly to drug treatment. Thus, patients may not respond similarly, or not at all, to certain drug treatments based on the affected HSC type.
EXPERIMENTAL PROCEDURES

Mice and Embryo Generation
Mice were bred and housed at Erasmus MC. BRE GFP transgenic mice (Monteiro et al., 2008) were maintained in C57BL/6 background. Matings were set up between heterozygous BRE GFP transgenic male and non-transgenic wild-type C57BL/66 female mice. The day of vaginal plug detection was designated as embryonic day 0. All animal procedures were approved by the Erasmus MC Ethical Review Board and performed in compliance with Standards for Care and Use of Laboratory Animals.
AGM Explant Culture
AGMs were dissected as previously described (Medvinsky and Dzierzak, 1996; Kumaravelu et al., 2002) . They were placed on a 0.65-mm Durapore filter on a sterile grid in six-well plates at the gas-liquid interface and cultured with Methocult 5300 or Stem Span serum-free medium (Stem Cell Technology) with 1% hydrocortisone (Sigma) and 1% PS, ± BMP4 (20 ng/ml), Shh (20 ng/ml), VEGF (50 ng/ml), and cyclopamine (Sigma, 5 mM) for 3 days at 37 C. Cells were prepared as previously described Table S2 . Chimerism was quantified by DNA PCR for gfp. DNA normalization (myoD) and comparison with gfp contribution controls was performed with Image Quant software. See Table S1 for PCR primer sequences. Mice showing >5% donor chimerism were considered repopulated.
Whole-Mount Immunostaining
Whole-mount embryo immunostaining was performed as described previously (Yokomizo and Dzierzak, 2010; Yokomizo et al., 2011) . 
Colony-Forming Unit Culture Assay
AGM cells were cultured in semisolid methylcellulose medium containing stem cell factor (SCF), IL-3, IL-6, Epo (Stem Cell Technologies), and 1% PS in 35-mm culture dishes at 37 C in a humidified chamber under 5% CO 2 . Burst forming unit-erythrocyte (BFU-E) and CFU-granulocyte (CFU-G), -macrophage (CFU-M), -granulocyte-macrophage (CFU-GM), and mixed colonies (CFU-GEMM) were distinguished based on their morphology and counted using an inverted microscope at day 10 of the culture.
The p values were calculated using the t test.
RNA Preparation, qRT-PCR, and RNA Sequencing
For qRT-PCR, total RNA was extracted using TRIzol Reagent (Invitrogen) and quantitated by a NanoDrop 8000 Spectrophotometer (Thermo Scientific, NanoDrop Technologies) or a 2100 Bioanalyzer (Agilent Technologies) with RNA 600 Pico chips (Agilent Technologies). cDNA was generated using SuperScript II Reverse Transcriptase (Invitrogen), from 1 mg of starting material. qRT-PCR primers (Table S1 ) were used with SYBR Green (Invitrogen) and Platinum Taq DNA Polymerase (Invitrogen), samples run on a CFX96 RealTime System C1000 Thermal Cycler (Bio-Rad), and analyzed with Bio-Rad CFX Manager v2.0 software. b-Actin was used as the internal reference. For RNA sequencing, RNA was isolated with the mirVana miRNA Kit and prepared according to SMARTER protocol for the Illumina HiSeq2000 sequencer. Sequences were mapped to the mouse (NCBI37UCSC/mm910) genome and FPKMs were calculated using Bowtie (v2.2.3), TopHat (v2.0.12), and Cufflinks (v2.2.1). Differential expression was analyzed using Cuffquant with fragment-bias and multi-read corrections, and normalized across all samples using Cuffnorm with geometric library-size normalization (Trapnell et al., 2013) . Difference in expression was calculated as GFP + FPKM+1/AGMin FPKM+1 with threshold of more than 2-fold change. Genes with more than 2-fold higher or lower expression in each comparison were applied to Enrichr tool. Enrichr output (and calculated p values from chi-squared tests) were imported into R and corrected for multiple testing (FDR), and a threshold of FDR < 0.05 was used. Hierarchical clusterings were performed using log10-transformed FPKMs of the top 10% most variable genes in the R statistical package using hclust() and dist() commands with default parameters. Heatmaps were generated using the R heatmap.2 package with row-scaling. For GSEA, ratios were calculated for AGMex HSPC GFP À versus GFP + FPKMs(+1) and used with GSEA (version 2.0.13) pre-ranked method using default options (Mootha et al., 2003; Subramanian et al., 2005) . RNAseq data are publicly available at NCBI GEO under accession number GEO: GSE76253.
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